These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12616199)

  • 1. Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection.
    Ahsan S; Telischi F; Hodges A; Balkany T
    Laryngoscope; 2003 Mar; 113(3):472-4. PubMed ID: 12616199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translabyrinthine vestibular schwannoma resection with simultaneous cochlear implantation.
    DeHart AN; Broaddus WC; Coelho DH
    Cochlear Implants Int; 2017 Sep; 18(5):278-284. PubMed ID: 28602150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.
    Kim JW; Han JH; Kim JW; Moon IS
    Yonsei Med J; 2016 Nov; 57(6):1535-9. PubMed ID: 27593888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).
    Arístegui M; Denia A
    Otol Neurotol; 2005 Mar; 26(2):205-10. PubMed ID: 15793406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear Implantation in a Patient with Neurofibromatosis Type 2 and an Intracochlear Schwannoma: A Case Report and Literature Review.
    Zhang D; Fu Z; Han S; Guo F; Tang N; Zhao Y; Guan G
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(5):425-428. PubMed ID: 35537404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
    Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
    Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous translabyrinthine removal of acoustic neuroma and cochlear implantation.
    Zanetti D; Campovecchi CB; Pasini S; Nassif N
    Auris Nasus Larynx; 2008 Dec; 35(4):562-8. PubMed ID: 18243617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery.
    Hassepass F; Arndt S; Aschendorff A; Laszig R; Wesarg T
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2373-83. PubMed ID: 26498948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [COCHLEAR IMPLANTATION FOR PATIENTS WITH CONSERVATIVELY TREATED VESTIBULAR SCHWANNOMA].
    Stern Shavit S; Adelman C; Yehezkely Kaufmann M
    Harefuah; 2023 Aug; 162(7):419-423. PubMed ID: 37561030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of Patients Undergoing Translabyrinthine Excision of Vestibular Schwannoma with Concurrent Cochlear Implantation.
    Rooth MA; Dillon MT; Brown KD
    Otol Neurotol; 2017 Dec; 38(10):1512-1516. PubMed ID: 29099442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
    Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
    Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear implants in the management of bilateral acoustic neuromas.
    Hoffman RA; Kohan D; Cohen NL
    Am J Otol; 1992 Nov; 13(6):525-8. PubMed ID: 1449178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic and NF2-associated vestibular schwannoma surgery and simultaneous cochlear implantation: a comparative systematic review.
    West N; Sass H; Cayé-Thomasen P
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):333-342. PubMed ID: 31802225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
    Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
    Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
    Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.